Cargando…
Traceable metallic antigen release for enhanced cancer immunotherapy
Tumor vaccine has shown outstanding advantages and good therapeutic effects in tumor immunotherapy. However, antigens in tumor vaccines can be easily cleared by the reticuloendothelium system in advance, which leads to poor therapeutic effect of tumor vaccines. Moreover, it was still hard to monitor...
Autores principales: | Lv, Fangfang, Jin, Yan, Feng, Xiaochen, Fan, Miao, Ren, Cui, Dai, Xinyue, Zhang, Jinchao, Li, Zhenhua, Jin, Yi, Liu, Huifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202220/ https://www.ncbi.nlm.nih.gov/pubmed/34149308 http://dx.doi.org/10.1007/s11051-021-05256-8 |
Ejemplares similares
-
Therapeutic exosomal vaccine for enhanced cancer immunotherapy by mediating tumor microenvironment
por: Lv, Fangfang, et al.
Publicado: (2021) -
Self‐Supply of O(2) and H(2)O(2) by a Nanocatalytic Medicine to Enhance Combined Chemo/Chemodynamic Therapy
por: Gao, Shutao, et al.
Publicado: (2019) -
Microbial hydrogen “manufactory” for enhanced gas therapy and self-activated immunotherapy via reduced immune escape
por: Yan, Hongyu, et al.
Publicado: (2022) -
Traceability
por: Ashford, Paul
Publicado: (2010) -
LEP Traceability
por: Billen, R
Publicado: (2000)